Johnson & Johnson
-0.8 %
5.09 %
Yet to be announced
Company Overview
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.
Revenue Sources
PassBased on SEC filings and company reports, Johnson & Johnson's revenue primarily comes from pharmaceutical products and medical devices. These products and services are considered halal as they contribute to human health and well-being. The company does not derive significant revenue from prohibited sources such as alcohol, gambling, or other haram activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 30, 2025 | $21.89b | $15.92b | - | $204.0m | 0.00% | 1.28% |
| Dec. 29, 2024 | $22.52b | $19.07b | - | $137.0m | 0.00% | 0.72% |
| Sept. 29, 2024 | $22.47b | $17.63b | - | $193.0m | 0.00% | 1.09% |
| June 30, 2024 | $22.45b | $16.44b | - | $270.0m | 0.00% | 1.64% |
Analysis of the last four quarters shows that interest expense as a percentage of total expenses remains consistently low. Interest income is reported as zero, indicating the company does not generate revenue from interest-bearing activities. The interest expense ratios for all quarters are well below the 5% threshold that would indicate material reliance on interest.
Operational Ethics
PassWhile Johnson & Johnson operates globally, research does not indicate significant ongoing collaborations with entities involved in human rights violations. The company maintains standard commercial operations in various countries but does not have material partnerships with governments or entities known for human rights violations.
Comments